The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities
Clinical trial NCT07381634 · RECRUITING
Trial details
- NCT number
- NCT07381634
- Sponsor
- First Affiliated Hospital of Wenzhou Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-30
- Primary completion
- 2026-12-20
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.